Vascular endothelial growth factor (VEGF) is one of the most important and specific factors affecting angiogenesis in tumor development.
Introduction
Lung cancer is one of the most common malignant neoplasms and the leading causes of death from cancer in men. Non-small cell lung cancer (NSCLC) constitutes 85% of all lung cancers and is a heterogeneous disease. Its most common histological types are adenocarcinoma (ADC) and squamous cell carcinoma (SCC). The key process in the NSCLC development is angiogenesis. One of the most important and specific factors affecting angiogenesis in tumor development is vascular endothelial growth factor VEGF [1] [2] . The main receptor through which VEGF transmits a signal to intracellular tyrosine kinase cascades is the VEGFR2 receptor encoded by the KDR gene [3] [4] . High VEGF expression is associated with tumor growth and metastatic process, while the inhibited VEGF expression results in suppressed tumor growth [5] . The VEGF gene also triggers the activation of the protease cascade involved in the degradation of extracellular matrix, suppressing apoptosis, stimulates the endothelial cells survival, increases vascular permeability, inhibits the dendritic cells differentiation as well as activates tissue factors and monocytes migration [6] . The VEGF gene is located on the short arm of chromosome 6 (6p21.3) and consists of eight exons and seven introns [7] , the KDR gene encoding the VEGFR2 receptor is located in the 4q11 -q12 region of chromosome 4 and contains 26 exons, 25 introns [8] . Polymorphic variants of the VEGF and KDR genes significantly influence the expression levels of the endothelial growth factor and its receptor, which leads to a change in the activation of angiogenesis in oncopathological processes. Therefore, the studies of molecular genetic disorders of these genes that will allow predicting the development and progress of this disease are of great importance.
In this research, we aim to study the relationship of the polymorphic variants rs2010963, rs699947, and rs3025039 of the VEGF gene and rs1870377 and rs2071559 of the KDR gene with the probability of development of an NSCLC specific histological type and clinical and morphological manifestations of this disease. 
Materials and Methods

Object of Research
Methods of Research
Isolation of total DNA from peripheral blood was carried out using the method described by Mathew [9] , followed by phenol-chloroform extraction and ethanol 
Statistical Processing of Results
The statistical analysis was carried out using the GraphPad InStat Version 3.05 application software and the SNPStats online program [10] . For the validity check, when comparing genotype frequencies in groups, the standard Pearson χ 2 criterion or the Fisher's exact test for small sampling were used. The relationship between genotypes, development and course of the disease was assessed according to the odds ratio (OR (95% CI)) using codominant and dominant SNPStats models.
Results
The association study between polymorphic variants of VEGF and KDR genes and the risk of ADC and SCC development showed ( Since the signal transmission from VEGF into the cell is carried out through its receptor VEGFR2 encoded by the KDR gene, combinations of polymorphic variants of the VEGF and KDR genes were analyzed. Table 3 shows only significant combinations of these genes that affect the likelihood of the disease development both in the general group of patients with NSCLC and when divided into groups with ADC and SCC. It was revealed that the patients-carriers of +936CT/−906CC combination had a reduced risk of NSCLC development.
When considering the effects of VEGF and KDR genotype combinations on the probability of a specific histological type of tumor development, it was found that +936CC/1719TT and +936CT/1719TT combinations are associated with the risk of development in specifically with ADC, but in the carriers of the homozygous combination +936CC/1719TT this association is of higher value (p = 0.02). The combination −634GC/1719TT reduces the risk of SCC development.
Analysis of the frequency distribution of polymorphic variants of genes under study in the groups of men and women with NSCLC is presented in Table 4 . At the next stage of work, the influence of molecular genetic disorders in the VEGF and KDR genes was studied for the probability of a certain histological type of NSCLC development in men and women. The frequency distribution of genotypes by the polymorphic loci of the VEGF gene in the control group and in the groups of patients with ADC and SCC, depending on gender, is presented in Table 5 . In women, there were no significant differences in the frequency occurrence of polymorphic VEGF gene variants between the control group and the patients with ADC and SCC ( Table 5 ).
It was established (
The assessed dependence of the degree of incidence of the primary NSCLC tumor on the polymorphic VEGF and KDR gene variants showed that in the carriers of −2578СС genotype of the VEGF gene the greater degree of incidence of the primary tumor (T2 -T4) is occurring more often (OR = 2.35; 95% CI: 1.21 -4.58; p = 0.02) than the smaller one (T1) (Figure 1 ).
Analysis of the relationship between the studied polymorphisms of VEGF and KDR genes with the primary tumor spread in men and women with NSCLC showed that −634GC genotype of the VEGF gene is more frequently occurring in women with a greater degree of the primary lesion spread (>3 cm) (OR = 4.80, 95%CI: 1.14 -20.09; p = 0.04) (Figure 2 ). There is also a tendency for the Table 6 ). In men, the association was not identified.
No association of polymorphic KDR gene variants was identified in men and
women with NSCLC with the presence of regional metastases.
Association analysis of VEGF gene haplotypes with regional metastases was carried out both in men and women with NSCLC. The statistical significance was reached only in the group of women as shown (Table 7) : [14] . These sequences can be involved in regulation of the studied gene transcription, which is directly related to the expression of the VEGF gene.
The genotype −634CC is associated with a higher serum concentration of VEGF as compared to CG and GG genotypes [15] [16] and with a higher vascular density in NSCLC cases [17] . . Polymorphism +936C > T of the VEGF gene is localized in the 3'-untranslated gene region and affects the circulating VEGF concentrations in plasma [20] directly triggering angiogenesis [21] , which can explain the risky significance in our population of +936T allele of the VEGF gene in men in the SCC development.
No such relationship was found in women with NSCLC. Squamous cell carcinoma is predominantly found in men and is hardly diagnosed in women, as known [22] . Therefore, in our study the associations found for SCC correspond to the data characterizing a group of male patients.
Polymorphic variants of the KDR gene do not separately influence the NSCLC development and its most common histological subtypes, but their combinations +936CC VEGF/1719TT KDR and +936CT VEGF/1719TT KDR significantly contribute to the risk of the ADC development. It is known that 1719A > T polymorphism of the KDR gene leads to the nonsynonymous substitution of amino acids, which affects the binding efficiency of VEGF to its VEGFR2 receptor [23] .
In addition to the angiogenesis induction in tumors, VEGF promotes the spread of the tumor process. In particular, it increases vascular permeability in tumors, induces serine proteases, inhibits apoptosis of epithelial cells, which [24] . Among the clinical and morphological parameters characterizing these processes, the present study takes into account a degree of primary tumor (T) spread, the presence of metastases in regional lymph nodes (N) and distant organs (M).
It is known that −634C allele of the VEGF gene is associated with a higher serum concentration of VEGF [14] . Among oncological patients with the GG genotype, the decreased expression of the VEGF gene is observed, and consequently, the primary lesion prevalence is lower than that in the GC and CC ge- 
Conclusion
Thus, the study showed that the development of squamous cell carcinoma is as- 
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